Cargando…

Dapagliflozin: Cardiovascular Safety and Benefits in Type 2 Diabetes Mellitus

Sodium-glucose co-transporter 2 inhibitors (SGLT2is) such as dapagliflozin, canagliflozin, and empagliflozin, are a promising new therapy in the treatment of type 2 diabetes mellitus (T2DM). SGLT2is can effectively reduce hyperglycemia thus improving glycemic control and they offer some beneficial e...

Descripción completa

Detalles Bibliográficos
Autor principal:	Saleem, Fatima
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2017
Materias:	Diabetes & Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716679/ https://www.ncbi.nlm.nih.gov/pubmed/29226041 http://dx.doi.org/10.7759/cureus.1751

Ejemplares similares

Use and effectiveness of dapagliflozin in patients with type 2 diabetes mellitus: a multicenter retrospective study in Taiwan
por: Chen, Jung-Fu, et al.
Publicado: (2020)

A randomised, controlled, double blind study to assess mechanistic effects of combination therapy of dapagliflozin with exenatide QW versus dapagliflozin alone in obese patients with type 2 diabetes mellitus (RESILIENT): study protocol
por: Brown, Emily, et al.
Publicado: (2021)

Effect of Dapagliflozin on Type 2 Diabetes Mellitus With Nonalcoholic Fatty Liver Disease: A Single-Center Survey
por: Das, Chandan, et al.
Publicado: (2021)

Expert Opinion About the Pharmacoeconomic Edge of Low-Cost Dapagliflozin in Type 2 Diabetes Mellitus in Indian Clinical Settings
por: Sharma, Kamal, et al.
Publicado: (2021)

Dapagliflozin Versus Vildagliptin as an Adjuvant to Metformin in Patients With Type 2 Diabetes Mellitus: A Randomized, Open-label Study
por: Gautam, Kumar, et al.
Publicado: (2023)

Compensatory changes in energy balance during dapagliflozin treatment in type 2 diabetes mellitus: a randomised double-blind, placebo-controlled, cross-over trial (ENERGIZE)—study protocol
por: Rajeev, Surya Panicker, et al.
Publicado: (2017)

Frequency of Urinary Tract Infections in Type 2 Diabetic Patients Taking Dapagliflozin
por: Khan, Sarfaraz, et al.
Publicado: (2022)

Correlation between Glycated Hemoglobin and Triglyceride Level in Type 2 Diabetes Mellitus
por: Naqvi, Syeda, et al.
Publicado: (2017)

Safety and Efficacy of Liraglutide on Cardiovascular Outcomes in Patients With Diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trials
por: Vemulapalli, Hema Srikanth, et al.
Publicado: (2023)

Dapagliflozin-induced Late-onset Euglycemic Diabetic Ketoacidosis
por: Iqbal, Iqra, et al.
Publicado: (2019)

External validation of a cardiovascular risk model for Omani patients with type 2 diabetes mellitus: a retrospective cohort study
por: Al Oraimi, Fatema, et al.
Publicado: (2023)

Impacts of type 2 diabetes mellitus and hypertension on the incidence of cardiovascular diseases and stroke in China real-world setting: a retrospective cohort study
por: Liu, Yan, et al.
Publicado: (2021)

Protocol for a randomised controlled trial of the effect of dapagliflozin, metformin and exercise on glycaemic variability, body composition and cardiovascular risk in prediabetes (the PRE-D Trial)
por: Færch, Kristine, et al.
Publicado: (2017)

Estimating direct medical costs of type 2 diabetes mellitus in the Philippines: a protocol
por: Ng, Junice Yi Siu, et al.
Publicado: (2020)

Understanding the cost of care of type 2 diabetes mellitus - a value measurement perspective
por: Doyle, Gerardine Anne, et al.
Publicado: (2022)

Incidence of Microalbuminuria and Factors Affecting It in Patients With Type 2 Diabetes Mellitus
por: Khan, Tayyab Mumtaz, et al.
Publicado: (2022)

Association between refill adherence to lipid-lowering medications and the risk of cardiovascular disease and mortality in Swedish patients with type 2 diabetes mellitus: a nationwide cohort study
por: Karlsson, Sofia Axia, et al.
Publicado: (2018)

Type 3 Diabetes Mellitus: A Link Between Alzheimer's Disease and Type 2 Diabetes Mellitus
por: Nisar, Omar, et al.
Publicado: (2020)

A four-year cardiovascular risk score for type 2 diabetic inpatients
por: Ramírez-Prado, Dolores, et al.
Publicado: (2015)

Effects of canagliflozin on cardiovascular risk factors in patients with type 2 diabetes mellitus
por: Budoff, Matthew J., et al.
Publicado: (2017)

Genetic polymorphism of the Dab2 gene and its association with Type 2 Diabetes Mellitus in the Chinese Uyghur population
por: Li, Yan-Peng, et al.
Publicado: (2023)

Safety and efficacy of insulin glargine 300 u/mL compared with other basal insulin therapies in patients with type 2 diabetes mellitus: a network meta-analysis
por: Freemantle, Nick, et al.
Publicado: (2016)

Early-Onset Type 2 Diabetes Mellitus
por: Sunny, Angel
Publicado: (2021)

Prevalence of Microalbuminuria in Type 2 Diabetes Mellitus
por: Sana, Muhammad Ahsan, et al.
Publicado: (2020)

Cognitive Impairment in Type 2 Diabetes Mellitus
por: Malik, Aimen, et al.
Publicado: (2022)

Anti-diabetic agents for prevention of type 2 diabetes mellitus in people with pre-diabetes: a systematic review and network meta-analysis protocol
por: Wang, Xianzhe, et al.
Publicado: (2019)

Tea consumption and risk of type 2 diabetes mellitus: a systematic review and meta-analysis update
por: Yang, Jian, et al.
Publicado: (2014)

Fruit and vegetable intake and risk of type 2 diabetes mellitus: meta-analysis of prospective cohort studies
por: Li, Min, et al.
Publicado: (2014)

The association between insulin therapy and depression in patients with type 2 diabetes mellitus: a meta-analysis
por: Bai, Xiaosu, et al.
Publicado: (2018)

Process evaluation of team-based care in people aged >65 years with type 2 diabetes mellitus
por: Sims Gould, Joanie, et al.
Publicado: (2019)

Effect of metformin on neurodegenerative disease among elderly adult US veterans with type 2 diabetes mellitus
por: Shi, Qian, et al.
Publicado: (2019)

The Association Between Deficiency of Vitamin D and Diabetes Mellitus Type 2 (DMT2)
por: Khudayar, Muhammad, et al.
Publicado: (2022)

Cardiovascular Risk Assessment Among People With Type 2 Diabetes Mellitus in Urban Slums of Central Karnataka, India
por: Davalagi, Shubha, et al.
Publicado: (2023)

Concurrent Presentation of Diabetic Nephropathy and Type 1 Diabetes Mellitus in a Pediatric Patient
por: Manazir, Sana, et al.
Publicado: (2021)

Type 1 diabetes mellitus and educational attainment in childhood: a systematic review
por: Oakley, Natalie Jayne, et al.
Publicado: (2020)

The association between serum uric acid and diabetic complications in patients with type 2 diabetes mellitus by gender: a cross-sectional study
por: Hu, Yimeng, et al.
Publicado: (2021)

Comparison of consumption behavior and appetite sensations among patients with type 2 diabetes mellitus after bariatric surgery
por: Yeh, Chun, et al.
Publicado: (2017)

Dapagliflozin-Associated Euglycemic Diabetic Ketoacidosis Presenting With Severe Abdominal Pain Mimicking Acute Peritonitis
por: Wang, Qianwen, et al.
Publicado: (2022)

The prevalence of type 2 diabetes mellitus among older people in Africa: a systematic review study protocol
por: Werfalli, Mahmoud, et al.
Publicado: (2014)

Association of the vitamin D binding protein polymorphisms with the risk of type 2 diabetes mellitus: a meta-analysis
por: Wang, Gaoshuai, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_vmpcjcpdhot85if83h893grg6s